Chams Holding Company Plc (NGX:CHAMS)

Verve Therapeutics Revenue

Chams Holding Company had revenue of 6.01B NGN in the quarter ending June 30, 2025, with 24.03% growth. This brings the company's revenue in the last twelve months to 16.41B, up 30.84% year-over-year. In the year 2024, Chams Holding Company had annual revenue of 14.84B with 53.86% growth.

• Revenue (ttm): 16.41B
• Revenue Growth: +30.84%
• P/S Ratio: 0.80
• Revenue / Employee: 863.44M
• Employees: 19
• Market Cap: 13.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.84B	5.20B	53.86%
Dec 31, 2023	9.65B	4.58B	90.40%
Dec 31, 2022	5.07B	1.74B	52.38%
Dec 31, 2021	3.32B	1.21B	57.48%
Dec 31, 2020	2.11B	-1.17B	-35.75%